Peter Greenleaf, CEO: Aurinia Pharmaceuticals AUPH Sell · Filed 24/02/22

Trade details

Type: Insider sale
Amount: $290,152.66
Shares · price: 33,047 sh · $8.78 a share
Held after: 982,671 sh
Stock: Aurinia Pharmaceuticals AUPH
Person: Peter GreenleafCEO
Trade date: 23/03/02
Filed: 24/02/22
Days to filing: 357 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Aurinia Pharmaceuticals trades, last 26 weeks

What else happened in Aurinia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/31~23/04/01

Peter Greenleaf's recent trades

Peter GreenleafFormer Affiliate
Planned saleAurinia Pharmaceuticals
Planned sale
Aurinia Pharmaceuticals
AUPH
$49.7M
3,136,201 sh
$49.7M
Filed 05/11
Traded 05/11
Peter GreenleafDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$8,053
377 sh
$8,053
Filed 04/06
Traded 04/02
Peter GreenleafDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$8,618
420 sh
$8,618
Filed 04/06
Traded 04/02
Peter GreenleafCEO
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$1.6M
195,593 sh
$1.6M
Filed 25/03/04
Traded 25/03/03
Peter GreenleafCEO
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$1.3M
164,947 sh
$1.3M
Filed 25/03/04
Traded 25/03/04